electroCore,

electroCore, Interest Expense

The Interest Expense of electroCore, (ECOR) as of Oct 19, 2026 is 572,000.00 USD. In the previous year, Interest Expense was 433,000.00 USD — a change of 32.10% (higher).

Interest Expense

572,000.00USD

YoY

32.10%

Last updated:

Interest Expense of electroCore, is 2024 572,000.00 USD. Interest Expense of electroCore, was 2023 433,000.00 USD. It decreases by 32.10% higher compared to the previous year.

The electroCore, Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-7.02 M USD
Jan 1, 2018
1.01 M USD
Jan 1, 2019
970,000.00 USD
Jan 1, 2020
80,000.00 USD
Jan 1, 2021
10,000.00 USD
Jan 1, 2022
290,000.00 USD
Jan 1, 2023
433,000.00 USD
Jan 1, 2024
572,000.00 USD
The electroCore, Interest Expense history
YEARInterest ExpenseYoY
572,000.00USD+32.10%
433,000.00USD+49.31%
290,000.00USD+2,800.00%
10,000.00USD-87.50%
80,000.00USD-91.75%
970,000.00USD-3.96%
1.01 MUSD-114.39%
-7.02 MUSD+811.69%
-770,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Interest Expense of electroCore, is 572,000.00 USD in 2024.

Interest Expense of electroCore, changed from 433,000.00 USD to 572,000.00 USD, representing a 32.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense electroCore, since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — electroCore,

All Key Metrics — electroCore,